|
MAVS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.762000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.118200E-01 |
| Normal-vs-Stage2 |
5.011800E-02 |
| Normal-vs-Stage3 |
8.38069999999913E-05 |
| Normal-vs-Stage4 |
3.522300E-03 |
| Stage1-vs-Stage2 |
6.648400E-02 |
| Stage1-vs-Stage3 |
4.50689999997866E-06 |
| Stage1-vs-Stage4 |
2.081900E-03 |
| Stage2-vs-Stage3 |
3.675600E-01 |
| Stage2-vs-Stage4 |
6.527800E-01 |
| Stage3-vs-Stage4 |
5.394200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.611600E-02 |
| Normal-vs-AfricanAmerican |
9.305600E-02 |
| Normal-vs-Asian |
8.707400E-01 |
| Caucasian-vs-AfricanAmerican |
9.027200E-01 |
| Caucasian-vs-Asian |
5.603400E-01 |
| AfricanAmerican-vs-Asian |
5.336400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.327600E-02 |
| Normal-vs-Female |
1.450830E-01 |
| Male-vs-Female |
2.740400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.232600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.295000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.678000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.215700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.900200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.061000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.709400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.476000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.994200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.384200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.019600E-02 |
| Normal-vs-Grade 2 |
4.293800E-01 |
| Normal-vs-Grade 3 |
4.479800E-03 |
| Normal-vs-Grade 4 |
5.65739999999204E-05 |
| Grade 1-vs-Grade 2 |
1.685910E-02 |
| Grade 1-vs-Grade 3 |
2.150200E-04 |
| Grade 1-vs-Grade 4 |
1.3186000002996E-07 |
| Grade 2-vs-Grade 3 |
8.978900E-03 |
| Grade 2-vs-Grade 4 |
2.41709999999618E-05 |
| Grade 3-vs-Grade 4 |
5.141600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.500400E-01 |
| Normal-vs-ccB subtype |
5.099400E-03 |
| ccA subtype-vs-ccB subtype |
2.444200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.321700E-02 |
| Normal-vs-N1 |
2.151000E-01 |
| N0-vs-N1 |
8.720000E-01 |
|
|
